New Enterprise Associates's Biotechnology Portfolio

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives.

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Cerecor discovers, develops and commercializes neuroscience drugs.

Slope.io is a provider of a healthcare software designed to offer an easy way to prevent inventory outages.

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

A biotechnology company developing RNA technologies to shape the future of gene therapy

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Tagworks Pharmaceuticals is a privately held biotech company

Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Pathos is a biotechnology company that leverages AI to accelerate oncology drug development.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Amber Therapeutics develops the next-generation of bioelectrical therapies.

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

SetPoint Medical provides a device-based therapy for rheumatoid arthritis.

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

ChromaCode is a molecular diagnostics company focusing on bioinformatics.

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

Moximed develops innovative therapies for patients with knee osteoarthritis.

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Our purpose is to make every pregnancy around the world safer.

U.S. Renal Care is a healthcare service provider that focuses on serving patients in dialysis facilities.

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Phathom Pharmaceuticals is a biopharmaceutical company.

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Recludix pharma is a developing platform to treat cancer patients.

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Ouroboros Medicines is a biotechnology company specializes in immunology.

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

Charm Therapeutics designs and develops small-molecule therapeutics that target the interaction between menin and the KMT2A protein.

Stablix Therapeutics is a biotechnology company pioneering the field of Targeted Protein Stabilization (TPS).

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.